• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
A-183. What are the fast acting insulins?
Insulin lispro, insulin aspart, insulin glulisine
A-183. First line medication after a T2DM dx and its MOA?
Metformin

Inhibit the absorption of glucose from gut, dec glucose output from liver, incr glucose uptake in adipose tissue and muscle
A-183. Rosiglitazone and pioglitazone MOA and have what ADRs?
MOA: sensitize skeletal muscle and fat to insulin (increase receptors)

Cause edema, new onset of CHF, exacerbation of pre-existing CHF, hepatotoxin (monitor LFTs)
A-183. Name, MOA, contraindications of GLP-1 analouges?
Exenatide and Liraglutide

Increase insulin release, decrease gastric emptying and inhibit glucagon release

Contra: T1DM, renal failure, conditions that cause decr GI motility. Increased risk of pancreatitis
A-183. Defect and labs of Type I-V hyperlipidemias?
1: lipoprotein lipase deficiency, abnormality or apo-CII defects - hi TGs, Chylos, and VLDL

2A: fucked up LDL receptors - hi LDL

2B: LDL hates their receptor - hi LDL and VLDL

3: Mutant apo E - hi chylos, VLDL, IDL, and LDL - decreased HDL

4: overprod of VLDL - low LDL and HDL

5: unknown - Hypercholes w/ low LDL and HDL
A-183. DOC for hyperTGs?
Clofibrate
A-183. Benefits of statins?
1.) decr HmG-CoA Reductase

2.) Decreased ACE = decr BP

3.) Decreased aldosterone = decr NADPH oxidase and oxidative damage at atherosclerotic sites.
A-183. How fibric acid agents like Colfibrate, fenofibrate, and gemfibrozil work to low TGs, for which they are the DOC?
Increase lipoprotien lipase activity thus decreasing chylos and VLDL by increasing tissue uptake of TGs
A-183. What are the first and second generation sulfonylureas and their MOA?
1st: Tolbutamide, Chlorpropamide, and Tolazamide

2nd: Glimepiride, Glyburide, Glipizide

MOA: promote insulin release from beta-islet cells
A-183. What are the intermediate and long acting insulins?
Intermediate: Lente

Long: Insulin glargine, insulin detemir, and protamine zinc insulin